| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 04/24/2013 | CN103058957A NMDA receptor antagonists for neuroprotection |
| 04/24/2013 | CN103058932A Synthetic method of N-(2-benzimidazolyl)-methyl carbamate |
| 04/24/2013 | CN103058931A Four 2-(3', 5'-dihalo-benzyl) benzimidazole type novel compounds and preparation method thereof |
| 04/24/2013 | CN102079729B Compounds with antiparasitic activity and medicaments containing them |
| 04/24/2013 | CN101550085B Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 04/23/2013 | US8426607 Substituted amino-benzimidazoles, medicaments comprimising said compound, their use and their method of manufacture |
| 04/23/2013 | US8426422 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 04/18/2013 | WO2013055793A1 Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer |
| 04/18/2013 | US20130096315 Certain chemical entities, compositions and methods |
| 04/18/2013 | US20130096137 Treating Sexual Desire Disorders with Flibanserin |
| 04/18/2013 | US20130095322 Novel yellow pigment composition, and method for producing yellow pigment microparticles |
| 04/17/2013 | EP2581449A2 Novel genes related to glutaminyl cyclase |
| 04/17/2013 | CN103044337A Synthetic method of 2-(N-alkyl)aminooimidazole derivatives |
| 04/16/2013 | US8420829 Processes for the preparation of bendamustine |
| 04/11/2013 | US20130090342 Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 04/10/2013 | EP2578573A1 Fused imidazole derivative |
| 04/10/2013 | CN101896470B Dual-acting benzoimidazole derivative and their use as antihypertensive agents |
| 04/09/2013 | US8415483 Compounds and their use as BACE inhibitors |
| 04/09/2013 | US8415328 Factor VIIa inhibitor |
| 04/09/2013 | CA2566431C Process for the preparation of telmisartan |
| 04/04/2013 | WO2013046223A1 An improved process for the preparation of bendamustine hydrochloride |
| 04/04/2013 | WO2009061730A3 4 -heteroaryl- substituted phenoxyphenylacetic acid derivatives as pgd2 inhibitors |
| 04/04/2013 | US20130085276 Carboxylation catalysts |
| 04/03/2013 | CN103012277A Process for synthesizing benzimidazole derivative |
| 04/03/2013 | CN101516834B Isoserine derivatives for use as coagulation factor IXa inhibitors |
| 04/03/2013 | CN101516833B Tartrate derivatives for use as coagulation factor IXa inhibitors |
| 04/02/2013 | US8410285 2′-halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists |
| 04/02/2013 | US8410283 Electrolyte additive of dye-sensitized solar cell and method of making the same |
| 04/02/2013 | CA2563167C Use of flibanserin in the treatment of premenstrual and other female sexual disorders |
| 04/02/2013 | CA2475633C Heteroaryl compounds useful as inhibitors of gsk-3 |
| 03/28/2013 | WO2012173521A3 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon |
| 03/28/2013 | US20130079376 Pyridyl-2-methylamino compounds, compositions and uses thereof |
| 03/28/2013 | US20130079339 Trpv1 vanilloid receptor antagonists with a bicyclic portion |
| 03/27/2013 | EP2571855A1 Novel prolylcarboxypeptidase inhibitors |
| 03/27/2013 | CN102993102A Synthetic method of [1-methyl-2-(8'-octyl hydroxamic acid group)-5-N,N-bi(2'-chloroethyl)]-1H-benzimidazole |
| 03/26/2013 | US8404860 Compound having hydantoin ring and method of producing the same |
| 03/21/2013 | WO2013040199A1 Process for the oxidation of hydrocarbons with the use of iridium metal catalyst complexes |
| 03/21/2013 | WO2013038944A1 Light-emitting element material and light-emitting element |
| 03/21/2013 | WO2013037960A1 Ep1 receptor ligands |
| 03/21/2013 | CA2848786A1 Ep1 receptor ligands |
| 03/21/2013 | CA2846397A1 Process for the oxidation of hydrocarbons with the use of iridium metal catalyst complexes |
| 03/20/2013 | EP2570125A1 Ep1 receptor ligands |
| 03/20/2013 | CN102985411A Imaging agents for detecting neurological disorders |
| 03/20/2013 | CN102977321A Compounds for use in electrolyte for solar cell, method for preparing the same, and electrolyte and solar cell having the same |
| 03/20/2013 | CN102977034A Amino acid base benzimidazole for asymmetric transfer hydrogenation reaction of ketone, and preparation method thereof |
| 03/20/2013 | CN102977033A Synthesis method of alpha-halogenated alkenyl amide |
| 03/20/2013 | CN102977032A Heterocyclic bridged biphenyls and their use in OLEDs |
| 03/20/2013 | CN102060793B Dual aryl tertiary amine azole compounds with biological activity as well as preparation method and medical application thereof |
| 03/20/2013 | CN102015658B Benzimidazole derivatives serving as calcium channel blocker |
| 03/14/2013 | WO2013036434A1 Tetrahydronaphthalene derivatives as t-type calcium channel blocker |
| 03/14/2013 | WO2013013113A3 Histone deacetylase 6 selective inhibitors for the treatment of bone disease |
| 03/14/2013 | WO2012127277A3 Bendamustine anionic-catioinic cyclopolysaccharide compositions |
| 03/14/2013 | US20130065896 Fused imidazole derivative |
| 03/13/2013 | CN102964307A Dabigatran etexilate related substance and preparation method thereof |
| 03/12/2013 | US8394969 Cyclic benzimidazole derivatives useful as anti-diabetic agents |
| 03/12/2013 | US8394968 Hepatitis C virus inhibitors |
| 03/12/2013 | US8394815 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 03/12/2013 | US8394803 Gyrase inhibitors and uses thereof |
| 03/07/2013 | WO2013029338A1 Novel compounds |
| 03/07/2013 | US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions |
| 03/07/2013 | US20130056075 Compounds for use in electrolyte for solar cell, method for preparing the same, and electrolyte and solar cell having the same |
| 03/06/2013 | EP2565185A1 [5,6]heterocyclic compound |
| 03/06/2013 | CN102958906A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389570 Hydroxamates as therapeutic agents |
| 03/05/2013 | US8389554 Imidazothiadiazole derivatives |
| 02/28/2013 | US20130053558 Organic compounds for electroluminescent devices |
| 02/28/2013 | US20130053412 Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use |
| 02/27/2013 | EP2561871A1 Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer |
| 02/27/2013 | CN102947964A Use of substituted perylenes in organic solar cells |
| 02/27/2013 | CN102947275A Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 02/27/2013 | CN102947274A Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 02/27/2013 | CN102153515B N,N'-bis-substituted urea Raf kinase inhibitors and preparation method and application thereof |
| 02/26/2013 | US8383832 Process for preparing benzimidazole compounds |
| 02/26/2013 | US8383662 Bicyclic heteroaryl compounds |
| 02/26/2013 | CA2679991C Processes for making zilpaterol and salts thereof |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | WO2013024394A1 Novel reference markers of dabigatran etexilate |
| 02/21/2013 | US20130046095 N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof |
| 02/21/2013 | US20130045488 Benzocyanine compounds |
| 02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |
| 02/20/2013 | CN102936223A Synthesis method and purification method of 5-iodo-2-methylbenzimidazole |
| 02/20/2013 | CN102153514B Method for preparing fluorine-containing benzyl benzimidazole compound |
| 02/19/2013 | US8377945 Small molecule inhibitors of spleen tyrosine kinase (SYK) |
| 02/14/2013 | WO2013020622A1 N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists |
| 02/14/2013 | US20130041002 Denibulin di-hydrochloride |
| 02/14/2013 | US20130040389 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex |
| 02/14/2013 | CA2844469A1 N- (benzimimdazol-2-yl) -cyclopropane carboxamides as lysophosphatidic acid antagonists |
| 02/13/2013 | EP2556058A1 Radioprotector compounds and methods |
| 02/13/2013 | CN102933557A Radioprotector compounds and methods |
| 02/13/2013 | CN102924385A Method for preparing 5-amino benzimidazolone with high purity by catalytic hydrogenation |
| 02/13/2013 | CN102924384A Derivatives having vinyl group and its use in electroluminescent element |
| 02/13/2013 | CN102002001B 2,2'-(1,4-phenylene) di(benzimidazole-5-carboxylic acid) and preparation method thereof |
| 02/07/2013 | WO2013018095A1 Compounds and compositions for use in augmentation of glucose uptake and insulin secretion |
| 02/07/2013 | WO2013017654A1 Novel estrogen receptor ligands |
| 02/07/2013 | WO2012073041A3 Inhibitors of apurinic/apyrimidinic endonuclease 1 (ape1) and their use |
| 02/07/2013 | US20130035487 Bioavailable Diacylhydrazine Ligands for Modulations the Expression of Exogenous Genes via an Ecdysone Receptor Complex |
| 02/07/2013 | US20130035480 Functionalization and purification of molecules by reversible group exchange |
| 02/07/2013 | US20130035337 Fused bicyclic heteroaryl derivative |
| 02/07/2013 | US20130034501 Diarylhydantoin compounds |